Sangart Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 35

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Sangart General Information

Description

Developer of oxygen therapeutics. The company offers Hemospan, a human hemoglobin-based product that delivers oxygen to tissues at risk of oxygen deprivation.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6175 Lusk Boulevard
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Biotechnology
Corporate Office
  • 6175 Lusk Boulevard
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sangart Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 31-Dec-2012 Completed Clinical Trials - Phase 2
11. Later Stage VC (Series G) 24-May-2012 Completed Generating Revenue
10. Later Stage VC 05-Oct-2010 Completed Generating Revenue
9. Later Stage VC (Series F) 12-Mar-2009 Completed Generating Revenue
8. Later Stage VC (Series E) 15-Aug-2006 Completed Generating Revenue
7. Later Stage VC 05-Sep-2003 Completed Startup
6. Later Stage VC (Series D1) 26-Aug-2003 Completed Startup
5. Later Stage VC 19-Jun-2003 Completed Startup
4. Later Stage VC (Series C) 25-Feb-2002 $1.54M $1.54M Completed Startup
3. Early Stage VC (Series B) Completed Startup
To view Sangart’s complete valuation and funding history, request access »

Sangart Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oxygen therapeutics. The company offers Hemospan, a human hemoglobin-based product that delivers oxygen to
Biotechnology
San Diego, CA
35 As of 2010

Mont-Saint-Guibert, Belgium
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sangart Competitors (40)

One of Sangart’s 40 competitors is NOVADIP, a Venture Capital-Backed company based in Mont-Saint-Guibert, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NOVADIP Venture Capital-Backed Mont-Saint-Guibert, Belgium
Regenxbio Formerly VC-backed Rockville, MD
Cerecin Venture Capital-Backed Broomfield, CO
Insception Lifebank Formerly PE-Backed Mississauga, Canada
Vivus Corporate Backed or Acquired Campbell, CA
You’re viewing 5 of 40 competitors. Get the full list »

Sangart Patents

Sangart Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130327677-A1 Packaging system for preserving a nonoxygenated hemoglobin based oxygen therapeutic product Active 15-Mar-2013
US-9174771-B2 Packaging system for preserving a nonoxygenated hemoglobin based oxygen therapeutic product Active 15-Mar-2013
AU-2014232540-A1 Polyalkylene oxide valerate hemoglobin conjugates Active 15-Mar-2013
AU-2014232540-B2 Polyalkylene oxide valerate hemoglobin conjugates Active 15-Mar-2013
CA-2906878-A1 Polyalkylene oxide valerate hemoglobin conjugates Active 15-Mar-2013 A61K38/42
To view Sangart’s complete patent history, request access »

Sangart Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sangart Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Banco Humanfond Venture Capital Minority
GZ Group Venture Capital Minority
Gambro Group Corporation Minority
Life Equity Sweden KB Venture Capital Minority
ODIN Forvaltning Asset Manager Minority
To view Sangart’s complete investors history, request access »

Sangart FAQs

  • When was Sangart founded?

    Sangart was founded in 1998.

  • Where is Sangart headquartered?

    Sangart is headquartered in San Diego, CA.

  • What is the size of Sangart?

    Sangart has 35 total employees.

  • What industry is Sangart in?

    Sangart’s primary industry is Biotechnology.

  • Is Sangart a private or public company?

    Sangart is a Private company.

  • What is Sangart’s current revenue?

    The current revenue for Sangart is .

  • How much funding has Sangart raised over time?

    Sangart has raised $266M.

  • Who are Sangart’s investors?

    Banco Humanfond, GZ Group, Gambro Group, Life Equity Sweden KB, and ODIN Forvaltning have invested in Sangart.

  • Who are Sangart’s competitors?

    NOVADIP, Regenxbio, Cerecin, Insception Lifebank, and Vivus are some of the 40 competitors of Sangart.

  • When was Sangart acquired?

    Sangart was acquired on 31-Dec-2012.

  • Who acquired Sangart?

    Sangart was acquired by Jefferies Financial Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process